{
    "id": 17853,
    "fullName": "NQO1 over exp",
    "impact": "none",
    "proteinEffect": "no effect",
    "geneVariantDescriptions": [
        {
            "description": "NQO1 over exp indicates an over expression of the Nqo1 protein. However, the mechanism causing the over expression is unspecified.",
            "references": [
                {
                    "id": 275,
                    "pubMedId": null,
                    "title": "External Reference Not Available (N/A)",
                    "url": "https://ckb.jax.org/about/glossaryOfTerms"
                }
            ]
        }
    ],
    "type": "non-specific",
    "gene": {
        "id": 1728,
        "geneSymbol": "NQO1",
        "terms": [
            "NQO1",
            "DHQU",
            "DIA4",
            "DTD",
            "NMOR1",
            "NMORI",
            "QR1"
        ]
    },
    "variant": "over exp",
    "createDate": "02/11/2016",
    "updateDate": "02/11/2016",
    "referenceTranscriptCoordinates": null,
    "partnerGenes": [
        
    ],
    "evidence": [
        {
            "id": 4448,
            "approvalStatus": "Preclinical - Cell line xenograft",
            "evidenceType": "Actionable",
            "efficacyEvidence": "In a preclinical study, CB-839 increased senstivity of KRAS-mutant pancreatic ductal carcinoma cells with NQO1-over expression to ARQ761 in culture, and CB-839 and ARQ761 in combination resulted in decreased tumor growth and extended median survival in NQO1-over expressing KRAS-mutant pancreatic ductal carcinoma cell line xenograft models (PMID: 26462257)",
            "molecularProfile": {
                "id": 18160,
                "profileName": "KRAS mut NQO1 over exp"
            },
            "therapy": {
                "id": 3517,
                "therapyName": "ARQ761 + CB-839",
                "synonyms": null
            },
            "indication": {
                "id": 3587,
                "name": "pancreatic ductal carcinoma",
                "source": "DOID"
            },
            "responseType": "sensitive",
            "references": [
                {
                    "id": 4555,
                    "pubMedId": 26462257,
                    "title": "Targeting glutamine metabolism sensitizes pancreatic cancer to PARP-driven metabolic catastrophe induced by \u00df-lapachone.",
                    "url": "http://www.ncbi.nlm.nih.gov/pubmed/26462257"
                }
            ],
            "ampCapAscoEvidenceLevel": "D",
            "ampCapAscoInferredTier": "II"
        }
    ],
    "molecularProfiles": [
        {
            "id": 18159,
            "profileName": "NQO1 over exp",
            "profileTreatmentApproaches": [
                
            ]
        },
        {
            "id": 18160,
            "profileName": "KRAS mut NQO1 over exp",
            "profileTreatmentApproaches": [
                
            ]
        }
    ],
    "allTranscriptCoordinates": [
        
    ]
}